Transcripta Bio

We’re thrilled to announce that Transcripta Bio took 1st place in the Genomics & Multiomics category at the AI Discovery Awards! A huge thank you to Nebius for hosting an inspiring event in Amsterdam and bringing together innovators from around the world. This recognition is a testament to our team’s dedication to advancing the frontiers of genomics and multiomics with cutting-edge AI. We’re excited to keep pushing boundaries and working with our partners and community to unlock new possibilities in life sciences. #Genomics #Multiomics #AI #AIawards #AIDrugDiscovery #Innovation #LifeSciences #TranscriptaBio

Earlier this week, we held the ceremony for the AI Discovery Award, our annual award recognizing startups leveraging AI in healthcare and life sciences. 🤍 We brought the participants together in Amsterdam for this special occasion. 257 applications, 103 reached the semifinals, 28 of those received honorable mentions, and 12 became winners across four categories. Meet them: Drug discovery: 🥇 Aikium Inc. 🥈 Serna Bio 🥉 Leash Bio Biotech: 🥇 Ataraxis AI  🥈 Feel Therapeutics  🥉 Nostics Genomics & multiomics: 🥇 Transcripta Bio 🥈 Converge Bio 🥉 Infinimmune Healthtech: 🥇 MetaSight Diagnostics 🥈 Slingshot AI  🥉 iSono Health The ceremony was hosted by our CCO Tom Blackwell and Global Head of Healthcare & Lifesciences Growth Dr. Ilya Burkov, with speakers including our CEO Arkady Volozh, Head of Healthcare and Life Sciences Artem Elmuratov and Global Sales Director Rashid Ivaev. Shout out to the presenters: Kamil Malisz, Anna Kostikova, Pavel Sinitcyn and Karina Morley — as well as to all the judges! We’ll return with the award in 2026! #AI #awards #drugdiscovery #biotech #genomics #healthtech

Transcripta Bio is collaborating with Microsoft Research to harness the power of AI and chemotranscriptomics in the search for new therapeutics. Our shared goal is to accelerate the journey from discovery to clinical candidate selection, with the potential to fast-track and deliver life-changing therapies to patients more efficiently. This is a powerful step toward a future where precision drug discovery is driven by the synergy of data, biology, and machine learning. Learn more: https://lnkd.in/gGRTE3Dg #MicrosoftResearch #TranscriptaBio #drugdiscovery #aidrugdiscovery

We have some exciting news! For the past year we have often wondered how to visually convey the dynamism of the transcriptome. We needed something that was iconic and robust, yet elegant and natural. As we searched, we came across the brilliant work of Simone Conradi Ph.D., which inspired our new brand language based on "Eigenfish". Clayton Mellina goes into more detail about the Eigenfish in the attached post, but here's a small preview of his explanation for why we like them. "Eigenfish embody the ethos of Charles Darwin’s famous quote: 'from so simple a beginning endless forms most beautiful and most wonderful have been, and are being, evolved.'" https://lnkd.in/g4K4bcsP

We have some exciting news! For the past year we have often wondered how to visually convey the dynamism of the transcriptome. We needed something that was iconic and robust, yet elegant and natural. As we searched, we came across the brilliant work of Simone Conradi Ph.D., which inspired our new brand language based on "Eigenfish". Clayton Mellina goes into more detail about the Eigenfish in the attached post, but here's a small preview of his explanation for why we like them. "Eigenfish embody the ethos of Charles Darwin’s famous quote: 'from so simple a beginning endless forms most beautiful and most wonderful have been, and are being, evolved.'" https://lnkd.in/g4K4bcsP

We are excited to announce our collaboration with SOLVE FSHD !

Thank you, Renee Y.! We are always excited to be a part of NVIDIA's HCLS ecosystem. We appreciate the inception team for their constant support of our innovation.

Thanks for support! NVIDIA's strong leadership in the life science ecosystem are pushing the field forward, and patients stand to benefit the most. Many of us at Transcripta Bio will be attending NVIDIA #GTC next month — please find us there if you are interested in connecting or learning more about how we are using computation to accelerate new therapies for patients! #RareDiseaseDay

🌟Thrilled to be chairing a dynamic panel discussion on The Future of Phenotypic Drug Discovery at #SLAS2025. Join our incredible panel of experts: Angela Oliveira Pisco, Director of Computational Biology insitro Christopher Moxham, CEO & Founder Transcripta Bio John Moffat, Distinguished Scientist Genentech Nasim J., Director of Morphological Profiling Ardigen Not attending SLAS this year? No problem! We want to hear from you. Take our 3-minute survey on the future of phenotypic drug discovery—your insights will help shape the discussion. Results will be shared during the session and with the broader community after the conference on LinkedIn. 🔗 Take the survey here: https://lnkd.in/es2Snj7P #SLAS2025 #PhenotypicDrugDiscovery #LifeSciences #Innovation #drugdiscovery #PhenotypicScreening #TranslationalResearch #ComputationalBiology #PrecisionMedicine #BioPharma

In Part 4 of The Biotech Startups Podcast conversation with Transcripta Bio Founder and CEO, Christopher Moxham, we explore the importance of finding your voice and sharing your ideas in the biotech industry.